Elementary bounds on Poincare and log-Sobolev constants for decomposable Markov chains

We consider finite-state Markov chains that can be naturally decomposed into smaller ``projection'' and ``restriction'' chains. Possibly this decomposition will be inductive, in that the restriction chains will be smaller copies of the initial chain. We provide expressions for Poincare (resp. log-Sobolev) constants of the initial Markov chain in terms of Poincare (resp. log-Sobolev) constants of the projection and restriction chains, together with further a parameter. In the case of the Poincare constant, our bound is always at least as good as existing ones and, depending on the value of the extra parameter, may be much better. There appears to be no previously published decomposition result for the log-Sobolev constant. Our proofs are elementary and self-contained.Comment: Published at http://dx.doi.org/10.1214/105051604000000639 in the Annals of Applied Probability (http://www.imstat.org/aap/) by the Institute of Mathematical Statistics (http://www.imstat.org

Dissolved Organic Matter Fractions and Their Removal in Full-Scale Drinking Water Treatment Process

Objectives The objective of this study is to investigate characteristics about removal of dissolved organic matter (DOM) and its fraction for improving operation efficiency in an advanced water treatment plant. Methods The monitoring of water quality was conducted at five processes such as raw water, pre-oxidation, after sedimentation, post-ozonation, after biological activated carbon (BAC) from July 2020 to August 2021 in advanced water treatment process (AWTP) supplying 180,000m3/day. The concentration of DOC (dissolved organic carbon) and number of algae were monitored and LC-OCD was used to fractionate DOC to four species, biopolymer (BP), humic substance (HS), building blocks (BB), and low molecular weights (LMWs). Results and Discussion The characteristics of raw water showed that the concentration of DOC and the number of algae increased with an increase in water temperature. The portion of BP and HS significantly increased at low and high water temperature, respectively, while BB and LMWs maintained the similar portion. The removal efficiency of DOC in the AWTP was achieved at 59% with each species of BP, HS, BB, and LMWs obtaining removal efficiency of 87%, 65%, 26%, and 52%, respectively. Coagulation/sedimentation/filtration showed removal efficiency of 84%, 56%, 20%, and 18% for BP, HS, BB, and LMWs, respectively, corresponding to their molecular weight. The effect of post-ozonation would be negligible except for BP. In BAC, removal efficiency of 49% and 12% were obtained for LMWs and BB (low molecular weight, respectively. As a result, the BP portion significantly decreased due to high removal efficiency, while BB portion was increased in the final treated water compared to raw water. Conclusion Most of DOM was removed in coagulation/sedimentation/filtration and BAC, whereas oxidation process such as pre-chlorination, pre-ozonation and post-oxidation did not have an effect on DOM removal. In coagulation/sedimentation/filtration, 84% and 54% of the BP and HS were removed, while BAC removed 49% and 12% of LMWs and BB, respectively. It has been recommended to improve the removal efficiency of BB, which obtained the lowest removal efficiency in AWTP, and to enhance the removal efficiency of LMWs in BAC to inhibit microbial regrowth in the distribution system

Laparoscopic Surgical Management and Clinical Characteristics of Ovarian Fibromas

Ovarian fibromas may be misdiagnosed as uterine myoma or ovarian malignant tumor. Laparoscopic examination appears to be an effective and safe surgical approach for managing ovarian fibromas

Comparison of Clinical Efficacy of Newfactan® versus Surfacten® for the Treatment of Respiratory Distress Syndrome in the Newborn Infants

Newfactan® is a domestically developed, bovine lung-derived, semi-synthetic surfactant. The aim of this study was to compare the clinical efficacy of Newfactan® with that of Surfacten® in the treatment of respiratory distress syndrome (RDS). Newfactan® or Surfacten® was randomly allocated to 492 newborn infants who were diagnosed as RDS and required surfactant instillation in four participating hospitals. The comparisons were made individually in two subsets of infants by birth weight (<1,500 g group [n=253] and ≥1,500 g group [n=239]). Short-term responses to surfactant and acute complications, such as the total doses of surfactant instilled, response type, extubation rate, ventilator settings, changes in respiratory parameters, air leak, patent ductus arteriosus, pulmonary hemorrhage, and intraventricular hemorrhage, and mortality during the 96 hr after surfactant instillation were measured. Long-term outcome and complications, such as total duration of intubation, bronchopulmonary dysplasia and periventricular leukomalacia, and ultimate mortality were measured. There were no significant differences in demographic and perinatal variables, short-term responses to surfactant and acute complications, and long-term outcome and complications between Newfactan® and Surfacten® in both birth weight groups. We concluded that Newfactan® was comparable to Surfacten® in the clinical efficacy in the treatment of RDS in both birth weight groups

Protective Effect of Sauchinone Against Regional Myocardial Ischemia/Reperfusion Injury: Inhibition of p38 MAPK and JNK Death Signaling Pathways

Sauchinone has been known to have anti-inflammatory and antioxidant effects. We determined whether sauchinone is beneficial in regional myocardial ischemia/reperfusion (I/R) injury. Rats were subjected to 20 min occlusion of the left anterior descending coronary artery, followed by 2 hr reperfusion. Sauchinone (10 mg/kg) was administered intraperitoneally 30 min before the onset of ischemia. The infarct size was measured 2 hr after resuming the perfusion. The expression of cell death kinases (p38 and JNK) and reperfusion injury salvage kinases (phosphatidylinositol-3-OH kinases-Akt, extra-cellular signal-regulated kinases [ERK1/2])/glycogen synthase kinase (GSK)-3β was determined 5 min after resuming the perfusion. Sauchinone significantly reduced the infarct size (29.0% ± 5.3% in the sauchinone group vs 44.4% ± 6.1% in the control, P < 0.05). Accordingly, the phosphorylation of JNK and p38 was significantly attenuated, while that of ERK1/2, Akt and GSK-3β was not affected. It is suggested that sauchinone protects against regional myocardial I/R injury through inhibition of phosphorylation of p38 and JNK death signaling pathways

Neuropharmacological Potential of Gastrodia elata

Research has been conducted in various fields in an attempt to develop new therapeutic agents for incurable neurodegenerative diseases. Gastrodia elata Blume (GE), a traditional herbal medicine, has been used in neurological disorders as an anticonvulsant, analgesic, and sedative medication. Several neurodegenerative models are characterized by oxidative stress and inflammation in the brain, which lead to cell death via multiple extracellular and intracellular signaling pathways. The blockade of certain signaling cascades may represent a compensatory therapy for injured brain tissue. Antioxidative and anti-inflammatory compounds isolated from natural resources have been investigated, as have various synthetic chemicals. Specifically, GE rhizome extract and its components have been shown to protect neuronal cells and recover brain function in various preclinical brain injury models by inhibiting oxidative stress and inflammatory responses. The present review discusses the neuroprotective potential of GE and its components and the related mechanisms; we also provide possible preventive and therapeutic strategies for neurodegenerative disorders using herbal resources

Reversible Pulmonary Hypertension in Adolescent with Left Atrial Myxoma

We report a patient of left atrial huge myxoma presenting with severe pulmonary hypertension in adolescents. A patient was a 14-year-old boy presented with sudden onset dyspnea. Transthoracic echocardiographic study revealed the presence of a nodular, 4.34 × 8.11 cm sized, mobile, hyperechoic mass in the left atrium and severe pulmonary hypertension with tricuspid insufficiency. After surgical therapy, tricuspid regurgitation and pulmonary hypertension was decreased and the patient was stabilized and had an uneventful clinical course